Labroots Cancer Research

Beware of vampires this Halloween, especially the cancer kind! buff.ly/rbvDJ4n

Missed the live event? No worries. Stream Labroots’ 9th Annual CRISPR Virtual Event Series on demand and explore expert insights advancing gene editing and CRISPR technology. 🎥 Watch for free: buff.ly/t1xCGpq #LRcrispr

Scientists discover that wound healing mechanisms help drive tumor resistance to chemotherapy. buff.ly/gR1pWAY

New evidence suggests that Dr. Rosalind Franklin was the first to recognize and discover the DNA double helix structure. buff.ly/uQHDscJ

A new report suggests that a simple assay can help identify which prostate cancer patients would most benefit from additional hormonal therapy. buff.ly/cAbOd3h

📢 Agilent Virtual Oncology Summit, Session 2: “Building Integrated Workflows for Oncology Research” 🗓️ Nov 3 | ⏰ 14:00-16:00 CET On demand through Nov 30. Register: buff.ly/lGHCZyv

See how 3D spheroid models and live-cell analysis were used to profile 880 FDA-approved compounds, uncovering cytotoxic, cytostatic, and disruptive responses. Learn how 3D assays can deliver richer data and improve in vitro to in vivo translation. buff.ly/PuMTDfr

🧬 Smarter cancer genomics workflows, from sample to insight. Join Day 2 of the Agilent Oncology Research Summit. 📅 3 Nov | 🕑 14:00 CET | 💻 Virtual buff.ly/q6Elbcq

Attending #SITC2026, hear Jeremiah Wala (Dana-Farber) present Orion spatial proteomics findings from a colorectal cancer immunotherapy trial. Nov 6, 6:45 PM | Exhibit Hall Visit @RareCyte Booth #1120! buff.ly/JhhNGxO

A new approval by the FDA clears the way for patients with metastatic prostate cancer to receive a combination of two drugs shown to extend survival. buff.ly/J7q3ijG

Recent clinical trial data suggests that a combination of two immunotherapies can prolong survival in patients with a subset of lung cancer. buff.ly/LkmI8uN

🔬 Agilent Oncology Research Summit 2026: two virtual sessions on molecular oncology, cancer genomics & precision medicine. 📅 Session 1 - Oct 29 : Molecular Oncology & Genomics 📅 Session 2 - Oct 15 : Integrated Oncology Workflows Sign up now: buff.ly/hu5B70D

Researchers find that proteins in the blood help assess prostate cancer risk. buff.ly/KTn4FIb

Join us on Nov. 5th for Emerging Tools for Functional Cell Sorting, an educational virtual event exploring how new large-particle workflows are expanding the possibilities of flow cytometry-based analysis and sorting. Register now: buff.ly/CnuoOqt

Not all multiplex immunofluorescence technologies are designed for the same objective. This guide compares the main categories and explains which workflows are best for discovery, biomarker development, and clinical research. buff.ly/IG6Pwv0

Scientists outline complex molecular pathway, providing insights into novel therapeutic targets to overcome cancer. buff.ly/XNoZzC0

A new study finds important prognostic value from a single photo of an individual’s face. buff.ly/xXGPTuC

The ovary has long been treated as an inert organ once menopause is over. 👵 A proteomic analysis of 28 donated ovaries found that they keep changing for decades afterward. 🔎 buff.ly/ZBPALSk

Gene‑modified CAR T cell therapies are transforming cancer treatment, but variability and manufacturing challenges remain. Discover high‑throughput strategies to characterize CAR T cells—activation, memory, exhaustion, cytokines, and killing. buff.ly/UvjkAwK

The first immunotherapy approach to treat locally advanced rectal cancer has been approved for use. buff.ly/DeLRObj